Rossari Biotech informs about updates

04 Apr 2026 Evaluate

Pursuant to Regulation 30(9) read with Schedule III of the Securities and Exchange Board of India (‘SEBI’) (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the ‘Listing Regulations’), as amended, Rossari Biotech has informed the Board of Directors of Unitop Chemicals, a material subsidiary (the ‘Subsidiary’) of the Company, at their meeting held on April 03, 2026, approved sale of its office premises located at Saki Naka, Mumbai at a consideration of ~ Rs. 10 crores. The proposed transaction is expected to be completed by end of Q2 FY27. As no business operations are conducted from the premises proposed to be sold by the Subsidiary, the sale will not have any impact on the Company’s or Subsidiary’s business operations. Further, the sale of the said premises does not constitute the sale of an undertaking within the meaning of Section 180(1)(a) of the Companies Act, 2013. The details required pursuant to Regulation 30 of the Listing Regulations read with SEBI Master Circular no. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026 shall be provided on execution of the agreement.

The above information is a part of company’s filings submitted to BSE.





Rossari Biotech Share Price

429.05 25.65 (6.36%)
02-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
BASF India 3314.05
Tata Chemicals 652.60
SRF 2415.35
Pidilite Inds. 1272.50
Deepak Nitrite 1377.70
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×